Ibrutinib for Relapsed or Refractory Mantle Cell Lymphoma

Clinical trial NCT04061850 · COMPLETED

Trial details

NCT number: NCT04061850
Sponsor: Samsung Medical Center
Status: COMPLETED
Study type: OBSERVATIONAL

Mantle Cell Lymphoma

Start date: 2019-07-01
Primary completion: 2020-03-31
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.